Similar Items: Reprogramming lipid metabolism for cognitive restoration in Alzheimer's via PLA2G4E
- Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum
- Metabolic and renal factors associated with plasma phosphorylated tau analytes used to detect Alzheimer's disease pathology
- Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
- Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
- Evaluation of fully automated ApoE4 proteotyping for APOE ε4 genotype estimation in the FINDERI cohort
- Alzheimer's disease drug development pipeline: 2026